ERSYNGA
Live / Applied — Fifth extension granted (statement of use) (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 05 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97396189
- Mark type
- Stylized text
- Filed
- 05 May 2022
- Published for opposition
- 07 Mar 2023
- Attorney of record
- Danielle R. Weitzman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological diseases and disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 11 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — SOU EXTENSION 5 GRANTED
- 18 Sept 2025 — SOU EXTENSION 5 FILED
- 09 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2025 — SOU EXTENSION 4 GRANTED
- 22 Apr 2025 — SOU EXTENSION 4 FILED
- 22 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2024 — SOU EXTENSION 3 GRANTED
- 25 Oct 2024 — SOU EXTENSION 3 FILED
- 25 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2024 — SOU EXTENSION 2 GRANTED